Magnesium sulfate in eclampsia and pre-eclampsia. Pharmacokinetic principles

Clinical Pharmacokinetics

Volumn 38, Issue 4, 2000, Pages 305-314

  Lu, Jian F ^a,b,c   Nightingale, Charles H ^b  

^a JINLING HOSPITAL   (China)

^b HARTFORD HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; MAGNESIUM SULFATE; NIFEDIPINE; SUXAMETHONIUM;

AMNION FLUID; BREATHING RATE; CHEMOPROPHYLAXIS; DIAPHRAGM PARALYSIS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG INFUSION; DRUG PROTEIN BINDING; DRUG URINE LEVEL; ECLAMPSIA; FECES IMPACTION; FEMALE; FETOTOXICITY; FLUSHING; HEADACHE; HEART ARREST; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; HYPOCALCEMIA; HYPOTHERMIA; LETHARGY; NAUSEA; NYSTAGMUS; PATIENT MONITORING; PREECLAMPSIA; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; REVIEW; TENDON REFLEX; URINE RETENTION; URINE VOLUME; VISUAL IMPAIRMENT;

EID: 0034010985     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-200038040-00002     Document Type: Review

References (70)

1. 1. Pritchard JA. Management of pre-eclampsia and eclampsia. Kidney Int 1980; 18: 259-66
2. 2. Saftlas AF, Olson DR, Franks AL, et al. Epidemiology of pre-eclampsia and eclampsia in the United Stales, 1979-1986. Am J Obstet Gynecol 1990; 163: 460-5
3. 3. Rosenfield A, Maine D. Maternal mortality - a neglected tragedy. Where is the M in MCH? Lancet 1985; 11 (8446): 83-5
4. 4. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and Caribbean. Br J Obstet Gynaecol 1992; 99: 547-53
5. 5. Redman CWG, Jefferies M. Revised definition of pre-eclampsia. Lancet; 1988: 1: 809-12
6. 6. Australasian Society for the Study of Hypertension in Pregnancy. Consensus statement: management of hypertension in pregnancy: executive summary. Med J Aust 1993; 158: 700-2
7. 7. Brown MA, Buddle ML. What's in a name? Problems with the classification of hypertension in pregnancy. J Hypertens 1997; 15: 1049-54
8. 8. Lazard EM. A preliminary report on the intravenous use of magnesium sulphate in puerperal eclampsia. Am J Obstet Gynecol 1925; 9: 178-88
9. 9. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet 1995; 345: 1455-63
10. 10. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995; 333: 201-5
11. 11. Coetzee EJ, Dommisse J, Anthony J. A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with pre-eclampsia. Br J Obstet Gynaecol 1998; 105: 300-3
12. 12. Sibai BM. Management of preeclampsia. Clin Perinatol 1991; 18: 793-808
13. 13. Duley L, Neilson JP. Magnesium sulphate and pre-eclampsia. Trial needed to see whether it's as valuable in pre-eclampsia as in eclampsia. BMJ 1999; 319: 3-4
14. 14. Sibai BM, Spinnato JA, Watson DL, et al. Effect of magnesium sulfate on electroencephalographic findings in pre-eclampsia-eclampsia. Obstet Gynecol 1984; 64: 261-6
15. 15. Del Castillo J, Engbaek L. The nature of neuromuscular block produced by magnesium. J Physiol 1954; 124: 370-3
16. 16. Idama TO, Lindow SW. Magnesium sulphate: a review of clinical pharmacology applied to obstetrics. Br J Obstet Gynecol 1998; 105: 260-8
17. 17. Villar MA, Sibai BM. Eclampsia. Obstet Gynecol Clin North Am 1988; 15: 355-77
18. 18. Friedman SA. Pre-eclampsia: a review of the role of prostaglandins. Obstet Gynecol 1988; 71: 122-37
19. 19. Watson KV, Moldow CE, Ogburn PL, et al. Magnesium sulfate: rationale for its use in pre-eclampsia. Proc Natl Acad Sci U S A 1986; 83: 1075-8
20. 20. Sipes LS, Weiner CP, Gellhaus TM, et al. Effect of magnesium sulphate infusion upon plasma prostaglandins in pre eclamptic and pre term labour. Hypertens Preg 1994; 13: 293-302
21. 21. Belfort MA, Moise Jr KJ. Effect of magnesium sulfate on maternal brain blood flow in pre-eclampsia: a randomized, placebo-controlled study. Am J Obstet Gynecol 1992; 167: 661-6
22. 22. Naidu S, Payne AJ, Moodley J, et al. Randomized study assessing the effect of phenytoin and magnesium sulphate on maternal cerebral circulation in eclampsia using transcranial Doppler ultrasound. Br J Obstet Gynaecol 1996; 103: 111-6
23. 23. Watkins JC, Evans RH. Excitatory amino acids transmitters. Annu Rev Pharmacol Toxicol 1981; 21: 165-204
24. 24. Watkins JC. Excitatory amino acids and central synaptic transmission. Trends Pharmacol 1984; 5: 373-76
25. 25. Cotton DB, Hallak M, Janusz C, et al. Central anticonvulsant effects of magnesium sulphate on N-methyl-D-aspartate-induced seizures. Am J Obstet Gynecol 1993; 168: 974-8
26. 26. Cotton DB, Janusz CA, Berman R. Anticonvulsant effects of magnesium sulphate on hippocampal seizures. Therapeutic implications in pre eclampsia-eclampsia. Am J Obstet Gynecol 1992; 166: 1127-36
27. 4 therapy in pre-eclampsia-eclampsia. Obstet Gynecol 1981; 57: 199-201
28. 28. Pritchard JA. The use of magnesium ion in the management of eclamptogenic toxemias. Surg Gynecol Obstet 1955; 100: 131-40
29. 29. Flowers CE, Eastetrics WE, White FD, et al. Magnesium sulfate in toxemia of pregnancy. Obstet Gynecol 1962; 19: 315-27
30. 30. Chesley LC, Tepper I. Plasma levels of magnesium attained in magnesium sulfate therapy for pre-eclampsia and eclampsia. Surg Clin North Am 1957; 37: 353-67
31. 31. Chesley LC, Tepper I. Some effects of magnesium loading upon renal excretion of magnesium and certain other electrolytes. J Clin Invest 1958; 37: 1362-72
32. 4 therapy of preeclamptic women. Acta Obstet Gynecol Scand 1995; 74: 517-9
33. 33. Chesley LC. Parenteral magnesium sulfate and the distribution, plasma levels, and excretion of magnesium. Am J Obstet Gynecol 1979; 133: 1-7
34. 34. Peiker G, Muller B, Erdmanm M, et al. The pharmacokinetics of magnesium sulfate in pregnant women with threatened abortion and fetal retardation. Pharmazie 1987; 42: 531-2
35. 35. Wang YL, Chen G. Pharmacodynamic modeling of cardiovascular effects of magnesium in pregnancy induced hypertensive gravidas. Chin J Clin Pharmacol 1994; 10 (2): 87-92
36. 36. Flowers CE. Magnesium sulfate in obstetrics. A study of magnesium in plasma, urine, and muscle. Am J Obstet Gynecol 1965; 91: 763-5
37. 37. Hall DG. Serum magnesium in pregnancy. Obstet Gynecol 1957; 9 (2): 158-66
38. 38. Brandt LJ, Glaser W, Jones A. Soft tissue distribution and plasma disappearance of intravenously administered isotopic magnesium with observations on uptake in bone. Metabolism 1958; 7: 355-61
39. 39. Fong J, Gurewitsch ED, Volpe L, et al. Baseline serum and cerebrospinal fluid magnesium levels in normal pregnancy and pre-eclampsia. Obstet Gynecol 1995; 85 (3): 444-8
40. 40. Thurnau GR, Kemp DB, Jarvis A. Cerebrospinal fluid levels of magnesium in patients with pre-eclampsia after treatment with intravenous magnesium sulfate: a preliminary report. Am J Obstet Gynecol 1987; 157: 1435-8
41. 41. Oppelt WW, Macintyre I, Rall DP. Magnesium exchange between blood and cerebrospinal fluid. Am J Physiol 1963; 205: 959-62
42. 2+ in the rabbit. Proc Soc Exp Biol Med 1960; 105: 957-9
43. 43. Mcguinness GA, Weinstein MM, Cruikshank DP, et al. Effect of magnesium sulfate treatment on perinatal calcium metabolism. II: neonatal responses. Obstet Gynecol 1980; 56: 595-600
44. 44. Cruikshank DP, Varner MW, Pitkin RM. Breast milk magnesium and calcium concentrations following magnesium sulfate treatment. Am J Obstet Gynecol 1982; 143: 685-8
45. 45. Cruikshank DP, Pitkin RM, Donnelly E, et al. Urinary magnesium, calcium, and phosphate excretion during magnesium sulfate infusion. Obstet Gynecol 1981; 58: 430-4
46. 46. Chen G, Li QN, Guo N. Studies on the pharmacokinetics and pharmacodynamics of MgSO4 in the treatment of pregnancy-induced hypertension. Chin J Clin Pharmacol 1991; 7 (2): 108-11
47. 47. Carney SL. Effect of magnesium deficiency on renal magnesium. J Clin Invest 1980; 65: 180-8
48. 48. Cruikshank DP, Pitkin RM, Reynolds WA, et al. Effects of magnesium sulfate treatment on perinatal calcium metabolism. I: maternal and fetal responses. Am J Obstet Gynecol 1979; 134: 243-9
49. 49. Petrie RH. Tocolysis using magnesium sulfate. Semin Perinatol 1981; 5: 266-73
50. 50. Perticone F, Adinolfi L, Bonaduce D. Efficacy of magnesium sulfate in the treatment of torsade de pointes. Am Heart J 1986; 112: 847-9
51. 51. Morris ME, LeRoy S, Sutton SC. Absorption of magnesium from orally administered magnesium sulfate in man. Clin Toxicol 1987; 25: 371-82
52. 52. Zuspan FP. Treatment of severe pre-eclampsia and eclampsia. Clin Obstet Gynecol 1966; 9: 945-72
53. 53. Pritchard JA. The use of magnesium sulfate in pre-eclampsia-eclampsia. J Reproduct Med 1979; 23: 107-14
54. 54. Sibai BM, Graham JM, McCubbin JH. A comparison of intravenous and intramuscular magnesium sulfate regimens in pre-eclampsia. Am J Obstet Gynecol 1984; 150: 728-33
55. 55. Sibai BM. Magnesium sulphate is the ideal anticonvulsant in pre-eclampsia-eclampsia. Am J Obstet Gynecol 1990; 162: 1141-5
56. 56. Winkler AW, Smith PK, Hoff HE. Intravenous magnesium sulphate in the treatment of nephritic convulsions in adults. J Clin Invest 1942; 21: 207-16
57. 57. McCubbin JH, Sibai BM, Abdella TN, et al. Cardiorespiratory arrest due to acute maternal hypermagnesaemia. Lancet 1981; I (8228): 1058
58. 58. Monif GRG, Savory J. Iatrogenic maternal hypocalcaemia following magnesium sulphate therapy. JAMA 1972; 219: 1469-70
59. 59. Eisenbud E, Lobue CC. Hypocalcaemia after therapeutic use of magnesium sulphate. Arch Intern Med 1976; 136: 688-91
60. 60. Lipsitz PJ, English IC. Hypermagnesemia in the newborn infant. Pediatrics 1967; 40: 856-62
61. 61. Stone SR, Pritchard JA. Effect of maternally administered magnesium sulfate in the neonate. Obstet Gynecol 1970; 35: 574-7
62. 62. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 1995; 95: 263-9
63. 63. Schendel DE, Berg CJ, Yeargin-Allsopp M, et al. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years. JAMA 1996; 276: 1805-11
64. 64. Paneth N, Jetton J, Pintomartin J, et al. Magnesium sulfate in labor and risk of neonatal brain lesions and cerebral palsy in low birthweight infants. Pediatrics 1997; 99: E11-6
65. 65. Mittendorf R, Covert R, Boman J, et al. Is tocolytic magnesium sulphate associated with increased total paediatric mortality? Lancet 1997; 350: 1517-8
66. 66. Ghoneim MM, Long JP. The interaction between magnesium and other neuromuscular blocking agents. Anesthesiology 1970; 32: 23-7
67. 67. Baraka A, Yazigi A. Neuromuscular interaction of magnesium with succinylcholine-vecuronium sequence in the eclamptic parturient. Anesthesiology 1987; 67: 806-8
68. 68. Vincent RD, Chestnut DH, Sipes SL, et al. Magnesium sulphate decreases maternal blood pressure but not uterine blood flow during epidural anaesthesia in gravid ewes. Anesthesiology 1991; 74: 77-82
69. 69. Lin CC, Pielet BW, Poon E, et al. Effect of magnesium sulphate on fetal heart rate variability in pre eclamptic patients during labour. Am J Perinatol 1988; 5: 208-13
70. 70. Fenakel K, Fenakel G, Appleman Z, et al. Nifedipine in the treatment of severe pre-eclampsia. Obstet Gynecol 1991; 77: 331-7